Greenwich LifeSciences, Inc. Proxy Summary (Schedule 14A)

Meeting Date: December 18, 2025. Record Date: October 28, 2025. 13,854,539 shares outstanding.

The Board urges stockholders to vote FOR both proposals.

Key Proposals:

• Election of Directors: Vote for five nominees, including CEO Snehal S. Patel and Chairman David B. McWilliams.
• Auditor Ratification: Ratify the appointment of MaloneBailey LLP for FY 2025. This follows the dismissal of RBSM LLP in July 2025.

Governance & Ownership:

• The Board structure maintains separation between CEO an